0001483813-13-000098.txt : 20130916
0001483813-13-000098.hdr.sgml : 20130916
20130916184624
ACCESSION NUMBER: 0001483813-13-000098
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130913
FILED AS OF DATE: 20130916
DATE AS OF CHANGE: 20130916
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HALOZYME THERAPEUTICS INC
CENTRAL INDEX KEY: 0001159036
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 880488686
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11388 SORRENTO VALLEY ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121-1345
BUSINESS PHONE: (858) 794-8889
MAIL ADDRESS:
STREET 1: 11388 SORRENTO VALLEY ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121-1345
FORMER COMPANY:
FORMER CONFORMED NAME: GLOBAL YACHT SERVICES INC
DATE OF NAME CHANGE: 20010912
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PATTON JOHN STUART
CENTRAL INDEX KEY: 0001247653
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32335
FILM NUMBER: 131099759
MAIL ADDRESS:
STREET 1: 150 INDUSTRIAL ROAD
STREET 2: C/O NEKTAR THERAPEUTICS
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2013-09-13
0
0001159036
HALOZYME THERAPEUTICS INC
HALO
0001247653
PATTON JOHN STUART
C/O HALOZYME THERAPEUTICS, INC.
11388 SORRENTO VALLEY ROAD
SAN DIEGO
CA
92121
1
0
0
0
Common Stock
2013-09-13
4
M
0
100000
0.39
A
230000
D
Common Stock
2013-09-13
4
S
0
37500
9.1029
D
192500
D
Common Stock
2013-09-16
4
S
0
37500
9.1648
D
155000
D
Option to Purchase Common Stock (NSO)
0.39
2013-09-13
4
M
0
100000
0.39
D
2004-12-09
2013-12-09
Common Stock
100000
0
D
This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $9.07 to $9.17. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer or a secruity holder of the Issuer full information regarding the number of shares sold at each separate price.
This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $9.075 to $9.24. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer or a secruity holder of the Issuer full information regarding the number of shares sold at each separate price.
By: Jean Liu, Attorney-in-fact For: John Stuart Patton
2013-09-16